- Home
- ESCA vs NGNE Comparison
ESCA vs NGNE Comparison
Compare ESCA & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESCA
- NGNE
- Stock Information
- Founded
- ESCA 1922
- NGNE 2003
- Country
- ESCA United States
- NGNE United States
- Employees
- ESCA N/A
- NGNE N/A
- Industry
- ESCA Recreational Games/Products/Toys
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- ESCA Consumer Discretionary
- NGNE Health Care
- Exchange
- ESCA Nasdaq
- NGNE Nasdaq
- Market Cap
- ESCA 198.2M
- NGNE 230.0M
- IPO Year
- ESCA N/A
- NGNE N/A
- Fundamental
- Price
- ESCA $15.11
- NGNE $17.36
- Analyst Decision
- ESCA
- NGNE Strong Buy
- Analyst Count
- ESCA 0
- NGNE 6
- Target Price
- ESCA N/A
- NGNE $60.80
- AVG Volume (30 Days)
- ESCA 15.1K
- NGNE 277.9K
- Earning Date
- ESCA 02-26-2025
- NGNE 11-18-2024
- Dividend Yield
- ESCA 3.97%
- NGNE N/A
- EPS Growth
- ESCA 35.81
- NGNE N/A
- EPS
- ESCA 0.94
- NGNE N/A
- Revenue
- ESCA $253,074,000.00
- NGNE $925,000.00
- Revenue This Year
- ESCA N/A
- NGNE N/A
- Revenue Next Year
- ESCA N/A
- NGNE N/A
- P/E Ratio
- ESCA $16.09
- NGNE N/A
- Revenue Growth
- ESCA N/A
- NGNE N/A
- 52 Week Low
- ESCA $12.34
- NGNE $14.42
- 52 Week High
- ESCA $16.99
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- ESCA 49.41
- NGNE 44.25
- Support Level
- ESCA $14.80
- NGNE $16.72
- Resistance Level
- ESCA $15.66
- NGNE $19.97
- Average True Range (ATR)
- ESCA 0.61
- NGNE 2.39
- MACD
- ESCA 0.02
- NGNE 0.08
- Stochastic Oscillator
- ESCA 42.33
- NGNE 19.43
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.